logo-large
  • Browse Categories

Publications by authors named "Catherine Huck"

Claim this Profile
R
Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis.
Barbara Nuesslein-Hildesheim, Enrico Ferrero, Cindy Schmid, Catherine Huck, Paul Smith

J Neuroinflammation· August 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys.
Diethilde Theil, Paul Smith, Catherine Huck, Yoann Gilbart, Algirdas Kakarieka

Front Immunol· October 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation.
Catherine Huck, David Leppert, Vanessa Wegert, Cindy Schmid, Robert Dunn

J Neuroimmune Pharmacol· December 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Valerie A Gerriets, Rigel J Kishton, Amanda G Nichols, Andrew N Macintyre, Makoto Inoue, Catherine Huck

J Clin Invest· January 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: